Co-Authors
This is a "connection" page, showing publications co-authored by THERESE BARTHOLOMEW BEVERS and BANU K ARUN.
Connection Strength
0.946
-
Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers. Breast Cancer Res Treat. 2022 Nov; 196(1):143-152.
Score: 0.220
-
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study. Cancer Prev Res (Phila). 2020 09; 13(9):795-802.
Score: 0.189
-
Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):880-915.
Score: 0.134
-
Exemestane in the prevention setting. Ther Adv Med Oncol. 2012 May; 4(3):107-12.
Score: 0.108
-
Breast cancer risk reduction. J Natl Compr Canc Netw. 2010 Oct; 8(10):1112-46.
Score: 0.096
-
Breast cancer risk reduction. J Natl Compr Canc Netw. 2007 Sep; 5(8):676-701.
Score: 0.078
-
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812). Cancer Prev Res (Phila). 2019 07; 12(7):481-490.
Score: 0.044
-
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. J Hum Nutr Diet. 2015 Jun; 28(3):272-82.
Score: 0.031
-
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila). 2012 Sep; 5(9):1144-54.
Score: 0.027
-
Building a predictive breast cancer risk model. AMIA Annu Symp Proc. 2007 Oct 11; 995.
Score: 0.020